喉がんの世界市場レポート 2025年

喉がんの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.7％で34億2,000万米ドルに成長します。成長の原動力となるのは、個別化医療に対する需要の高まり、遠隔腫瘍学や高度診断の幅広い導入、遺伝子プロファイリングやバイオマーカーの利用拡大、ベイプや電子タバコの人気の高まり、肥満や座りがちなライフスタイルの増加などです。予測期間中に予想される主な動向には、治療アプローチの革新、新技術を用いた診断ツールの強化、新薬と治療法の出現、予測診断のためのAIと機械学習の利用、音声療法ソリューションのデジタル統合などがあります。

喫煙人口の増加は、今後数年間の喉がん市場の成長を促進すると予測されます。喫煙人口とは、特定の地域で一貫してタバコ製品を消費している個人の割合または数を指します。この喫煙人口はストレスレベルの上昇により増加しており、対処戦略として喫煙に頼る人が増えています。喉がんは、喫煙に伴う深刻な健康リスクを浮き彫りにしており、喫煙者の喫煙の発生を減らすための公衆意識と予防努力の緊急の必要性を強調しています。例えば、2024年10月、スイスを拠点とする非営利団体である欧州呼吸器学会（ERS）は、若年層の喫煙率が2022年の22.5％から2024年には40.1％へと大幅に上昇すると報告しました。その結果、喫煙人口の増加が喉がん市場の拡大に寄与しています。

喉がん市場の主要企業は、治療効果と患者の生存率を向上させるため、免疫腫瘍薬などの革新的な治療法の開発に力を入れています。免疫腫瘍薬は、がん細胞を検出・破壊するために身体の免疫システムを利用し、より的を絞った効率的な治療アプローチを提供します。例えば、2024年11月、インドの製薬会社Dr.Reddy's Laboratories Ltd.は、喉がんの希少で侵攻性の高いタイプである上咽頭がんの治療薬としてToripalimabを発売しました。この革新的な治療法は、PD-1受容体を標的とした免疫チェックポイント阻害を活用することにより、免疫系ががん細胞をよりよく認識し排除できるようにするものです。Toripalimabは、選択肢が限られている患者に新たな治療選択肢を提供し、生存成績とQOLを向上させる可能性があります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の喉がん：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の喉がん市場：成長率分析
• 世界の喉がん市場の実績：規模と成長、2019～2024年
• 世界の喉がん市場の予測：規模と成長、2024～2029年、2034年
• 世界の喉がん：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の喉がん市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 喉がん
• 喉頭がん
• 世界の喉がん市場：治療法別、実績と予測、2019～2024年、2024～2029年、2034年
• 手術
• 放射線治療
• 標的療法
• 化学療法
• 代謝拮抗剤
• 白金誘導体
• 植物由来成分
• 窒素マスタード類
• 抗生物質
• その他
• 世界の喉がん市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• がん研究機関
• 多科クリニック
• 外来手術センター
• 世界の喉がん市場：喉がんのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 中咽頭がん
• 鼻咽頭がん
• 下咽頭がん
• 世界の喉がん市場：喉頭がんのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 声門がん
• 声門上がん
• 声門下がん

第7章 地域別・国別分析

• 世界の喉がん市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の喉がん市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 喉がん市場：競合情勢
• 喉がん市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bristol Myers Squibb
• AstraZeneca plc
• Novartis AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Astellas Pharma Inc.
• Dr. Reddy's Laboratories
• Biocon Ltd.
• Coherus BioSciences Inc.
• Inovio Pharmaceuticals Inc.
• Boston Biomedical Inc.
• Shanghai Sunway Biotech Co. Ltd.
• Odon Life Sciences

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 喉がん市場2029年：新たな機会を提供する国
• 喉がん市場2029年：新たな機会を提供するセグメント
• 喉がん市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Throat cancer is characterized by the development of malignant cells within the throat tissues, encompassing areas such as the pharynx, larynx, and tonsils. Common symptoms include a persistent sore throat, hoarseness, and difficulty swallowing. The condition is frequently associated with risk factors like tobacco use, alcohol consumption, and infection with the human papillomavirus (HPV).

There are two primary forms of throat cancer: pharyngeal cancer and laryngeal cancer. Pharyngeal cancer arises in the pharynx-the section of the throat located behind the nose and mouth-and can impact specific regions including the nasopharynx, oropharynx, and hypopharynx. Available treatments range from surgery and radiation therapy to chemotherapy, targeted therapy, antimetabolites, platinum-based drugs, plant-derived treatments, nitrogen mustard agents, antibiotics, and others. These therapies are administered across various end-user settings such as hospitals, multispecialty clinics, cancer research centers, and ambulatory surgical units.

The throat cancer market research report is one of a series of new reports from The Business Research Company that provides throat cancer market statistics, including the throat cancer industry's global market size, regional shares, competitors with the throat cancer market share, detailed throat cancer market segments, market trends and opportunities, and any further data you may need to thrive in the throat cancer market. This throat cancer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The throat cancer market size has grown strongly in recent years. It will grow from $2.25 billion in 2024 to $2.45 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. Growth during the historical period was supported by an increase in smoking rates, a surge in alcohol consumption, a rise in HPV infections, greater prevalence of gastroesophageal reflux disease (GERD), and worsening urban air pollution levels.

The throat cancer market size is expected to see strong growth in the next few years. It will grow to $3.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. Projected growth will be driven by increased demand for personalized medicine, broader adoption of tele-oncology and advanced diagnostics, greater use of genetic profiling and biomarkers, rising popularity of vaping and e-cigarettes, and an uptick in obesity and sedentary lifestyles. Key trends anticipated in the forecast period include innovations in treatment approaches, enhanced diagnostic tools using novel technologies, the emergence of new drugs and therapies, use of AI and machine learning for predictive diagnostics, and the digital integration of speech therapy solutions.

The rise in the smoking population is anticipated to drive the growth of the throat cancer market in the coming years. The smoking population refers to the proportion or number of individuals in a specific area who consistently consume tobacco products. This population is increasing due to higher stress levels, prompting more individuals to turn to smoking as a coping strategy. Throat cancer highlights the serious health risks associated with smoking, underscoring the urgent need for public awareness and preventive efforts to reduce its occurrence among smokers. For example, in October 2024, the European Respiratory Society (ERS), a Switzerland-based non-profit organization, reported a significant increase in smoking rates among young people, rising from 22.5% in 2022 to 40.1% in 2024. As a result, the growing smoking population is contributing to the expansion of the throat cancer market.

Leading companies in the throat cancer market are emphasizing the development of innovative therapies, such as immuno-oncology drugs, to improve treatment effectiveness and patient survival rates. Immuno-oncology drugs utilize the body's immune system to detect and destroy cancer cells, offering a more targeted and efficient treatment approach. For instance, in November 2024, Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical company, launched Toripalimab to treat nasopharyngeal carcinoma, a rare and aggressive type of throat cancer. This innovative therapy leverages immune checkpoint inhibition by targeting the PD-1 receptor, thereby enabling the immune system to better recognize and eliminate cancer cells. Toripalimab provides a new therapeutic option for patients with limited choices, potentially enhancing survival outcomes and quality of life.

In January 2024, Inovio Pharmaceuticals Inc., a US-based biotechnology company, entered into a partnership with Coherus BioSciences to advance DNA-based immunotherapies for cancer. The collaboration aims to accelerate the development of INO-3112 in combination with LOQTORZ to treat HPV-associated cancers more effectively. Through this partnership, the companies seek to improve patient outcomes by utilizing cutting-edge immunotherapy methods. Coherus BioSciences Inc. is a US-based firm specializing in the development and commercialization of immuno-oncology treatments for difficult-to-treat cancers.

Major players in the throat cancer market are Pfizer Inc., Roche Holding AG, Merck and Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Astellas Pharma Inc., Dr. Reddy's Laboratories, Biocon Ltd., Coherus BioSciences Inc., Inovio Pharmaceuticals Inc., Boston Biomedical Inc., Shanghai Sunway Biotech Co. Ltd., and Odon Life Sciences.

North America was the largest region in the throat cancer market in 2024. The regions covered in throat cancer report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the throat cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The throat cancer market consists of revenues earned by entities by providing services such as diagnostic services, immunotherapy services, palliative care services, and rehabilitation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The throat cancer market also includes sales of chemotherapy drugs, radiation therapy equipment, immunotherapy drugs, targeted therapy drugs, and surgical instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Throat Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on throat cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for throat cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The throat cancer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Types: Pharyngeal Cancer; Laryngeal Cancer
• 2) By Treatments: Surgery; Radiation Therapy; Targeted Therapy; Chemotherapy; Antimetabolites; Platinum Derivatives; Plant Derivatives; Nitrogen Mustards; Antibiotics; Other Treatments
• 3) By End-User: Hospitals; Cancer Research Institutes; Multispecialty Clinics; Ambulatory Surgical Centers

Subsegments

• 1) By Pharyngeal Cancer: Oropharyngeal Cancer; Nasopharyngeal Cancer; Hypopharyngeal Cancer
• 2) By Laryngeal Cancer: Glottic Cancer; Supraglottic Cancer; Subglottic Cancer
• Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck and Co. Inc.; AbbVie Inc.; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Throat Cancer Market Characteristics

3. Throat Cancer Market Trends And Strategies

4. Throat Cancer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Throat Cancer Growth Analysis And Strategic Analysis Framework

• 5.1. Global Throat Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Throat Cancer Market Growth Rate Analysis
• 5.4. Global Throat Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Throat Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Throat Cancer Total Addressable Market (TAM)

6. Throat Cancer Market Segmentation

• 6.1. Global Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharyngeal Cancer
• Laryngeal Cancer
• 6.2. Global Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Radiation Therapy
• Targeted Therapy
• Chemotherapy
• Antimetabolites
• Platinum Derivatives
• Plant Derivatives
• Nitrogen Mustards
• Antibiotics
• Other Treatments
• 6.3. Global Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Cancer Research Institutes
• Multispecialty Clinics
• Ambulatory Surgical Centers
• 6.4. Global Throat Cancer Market, Sub-Segmentation Of Pharyngeal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oropharyngeal Cancer
• Nasopharyngeal Cancer
• Hypopharyngeal Cancer
• 6.5. Global Throat Cancer Market, Sub-Segmentation Of Laryngeal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glottic Cancer
• Supraglottic Cancer
• Subglottic Cancer

7. Throat Cancer Market Regional And Country Analysis

• 7.1. Global Throat Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Throat Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Throat Cancer Market

• 8.1. Asia-Pacific Throat Cancer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Throat Cancer Market

• 9.1. China Throat Cancer Market Overview
• 9.2. China Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Throat Cancer Market

• 10.1. India Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Throat Cancer Market

• 11.1. Japan Throat Cancer Market Overview
• 11.2. Japan Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Throat Cancer Market

• 12.1. Australia Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Throat Cancer Market

• 13.1. Indonesia Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Throat Cancer Market

• 14.1. South Korea Throat Cancer Market Overview
• 14.2. South Korea Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Throat Cancer Market

• 15.1. Western Europe Throat Cancer Market Overview
• 15.2. Western Europe Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Throat Cancer Market

• 16.1. UK Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Throat Cancer Market

• 17.1. Germany Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Throat Cancer Market

• 18.1. France Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Throat Cancer Market

• 19.1. Italy Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Throat Cancer Market

• 20.1. Spain Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Throat Cancer Market

• 21.1. Eastern Europe Throat Cancer Market Overview
• 21.2. Eastern Europe Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Throat Cancer Market

• 22.1. Russia Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Throat Cancer Market

• 23.1. North America Throat Cancer Market Overview
• 23.2. North America Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Throat Cancer Market

• 24.1. USA Throat Cancer Market Overview
• 24.2. USA Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Throat Cancer Market

• 25.1. Canada Throat Cancer Market Overview
• 25.2. Canada Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Throat Cancer Market

• 26.1. South America Throat Cancer Market Overview
• 26.2. South America Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Throat Cancer Market

• 27.1. Brazil Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Throat Cancer Market

• 28.1. Middle East Throat Cancer Market Overview
• 28.2. Middle East Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Throat Cancer Market

• 29.1. Africa Throat Cancer Market Overview
• 29.2. Africa Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Throat Cancer Market Competitive Landscape And Company Profiles

• 30.1. Throat Cancer Market Competitive Landscape
• 30.2. Throat Cancer Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Throat Cancer Market Other Major And Innovative Companies

• 31.1. Bristol Myers Squibb
• 31.2. AstraZeneca plc
• 31.3. Novartis AG
• 31.4. GlaxoSmithKline plc
• 31.5. Takeda Pharmaceutical Company Limited
• 31.6. Eli Lilly and Company
• 31.7. Amgen Inc.
• 31.8. Astellas Pharma Inc.
• 31.9. Dr. Reddy's Laboratories
• 31.10. Biocon Ltd.
• 31.11. Coherus BioSciences Inc.
• 31.12. Inovio Pharmaceuticals Inc.
• 31.13. Boston Biomedical Inc.
• 31.14. Shanghai Sunway Biotech Co. Ltd.
• 31.15. Odon Life Sciences

32. Global Throat Cancer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Throat Cancer Market

34. Recent Developments In The Throat Cancer Market

35. Throat Cancer Market High Potential Countries, Segments and Strategies

• 35.1 Throat Cancer Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Throat Cancer Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Throat Cancer Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer